what are the Recommendations for Antithrombotic Therapy for Prosthetic Valves
(Continued)?
For patients with a bioprosthetic SAVR or mitral valve replacement who are at low risk of bleeding, anticoagulation with a VKA to achieve an INR of 2.5 is reasonable for at least 3 months and for as long as 6 months after surgical replacement.